American consumers pay hundreds of billion of dollars in inflated pharmaceutical prices because drug companies are legal monopolies, a result of current patent laws. Dean Baker of the Center for Economic and Policy Research evaluates 4 separate strategies for slashing the cost of drugs and seeing drugs as a common good.
